cagrilintide and semaglutide 2.4 mg Updates in Medicine | CagriSema in Adults With or Without Diabetes – REDEFINE 1 & 2 • 💊 + 2.4 mg once weekly • 📉 –20.4% weight 1 CagriSema 2.4 mg /

Taken together, these data reinforce the emerging paradigm of a multimodal and personalized therapeutic approach, which will likely form the foundation of future obesity management

Mobilizes fat, clears via bile acid transport, oxidizes mitochondrially, and suppresses new adipogenesis simultaneously

Switching medications may be considered if a patient experiences side effects, supply issues, or if a different treatment option is better suited to their needs

Patients should seek medical attention if they experience symptoms like right upper abdominal pain, fever, or yellowing of the skin or eyes

doi: 10.1007/s40256-024-00673-1 25 Fonseca-CorreaJICorrea-RotterR